Table 1.
Demographic and clinical characteristics of subjects presenting with stroke. Data are counts (n) and percentages (%), means and standard deviations (SD), or medians and interquartile ranges (IQR).
| Ischemic stroke, n (%) | Hemorrhagic stroke, n (%) | Total, n (%) | |
|---|---|---|---|
| Sample size | 69 (46.3) | 80 (53.7) | 149 |
| Age in years, mean ± SD | 60.2 ± 13.6 | 54.7 ± 15.0 | 57.2 ± 14.6 |
| Female | 35 (50.7) | 37 (46.3) | 72 (48.3) |
| Employment status | |||
| Employed | 28 (40.6) | 34 (42.5) | 62 (41.6) |
| Peasant | 11 (15.9) | 5 (6.3) | 18 (12.1) |
| Homemaker | 9 (13.0) | 9 (11.3) | 43 (28.9) |
| Unemployed | 14 (20.3) | 29 (36.3) | 16 (10.7) |
| Retired | 7 (10.1) | 3 (3.8) | 10 (6.7) |
| Self-Reported Risk Factors | |||
| Hypertension | 56 (81.2) | 68 (85.0) | 124 (83.2) |
| Diabetes mellitus | 22 (31.9) | 6 (7.5) | 28 (18.8) |
| Obesity/Overweight | 8 (11.6) | 10 (12.5) | 18 (12.1) |
| Family history of stroke | 11 (15.9) | 20 (25.0) | 31 (20.8) |
| Prior stroke | 16 (23.2) | 8 (10.0) | 24 (16.1) |
| Smoking (current or prior) | 7 (10.1) | 6 (7.5) | 13 (8.7) |
| Illicit drug or alcohol use | 13 (18.8) | 9 (11.3) | 22 (14.8) |
| Prior Medicationsa | |||
| Aspirin | 13 (18.8) | 4 (5.0) | 17 (11.4) |
| Clopidogrel | 4 (5.8) | 4 (2.7) | |
| Antihypertensive | 36 (52.2) | 37 (46.3) | 73 (49.0) |
| Statin | 5 (7.2) | 1 (1.3) | 6 (4.0) |
| Oral contraceptive | 1 (1.4) | 2 (2.5) | 3 (2.0) |
| Hypoglycemic | 12 (17.4) | 1 (1.3) | 13 (8.7) |
| Initial examination | |||
| Limb weakness | 66 (95.7) | 73 (91.3) | 139 (93.3) |
| Altered level of consciousness | 29 (42.0) | 44 (55.0) | 73 (49.0) |
| Aphasia | 25 (36.2) | 29 (36.3) | 54 (36.2) |
| NIH stroke scale score, median (IQR) | 19 (13,25) | 19 (13,27) | 19 (13,26) |
| Intake Blood Pressure in mmHg, mean ± SD | |||
| Systolic | 150.8 ± 23.3 | 164.6 ± 25.6 | 158.2 ± 25.4 |
| Diastolic | 90.2 ± 18.4 | 99.1 ± 18.5 | 95.0 ± 18.9 |
| Intake Heart Rate, beats per minute, mean ± SD | 92.6 ± 20.3 | 86.6 ± 20.2 | 89.4 ± 20.4 |
| HIV infection | 4 (6.0) | 8 (10.4) | 12 (8.3) |
| Blood Glucose, mmol/l | 8.6 ± 4.0 | 7.8 ± 3.8 | 8.2 ± 3.9 |
| Serum Sodium, μmol/l | 135.8 ± 10.0 | 136.2 ± 11.6 | 136.0 ± 10.9 |
| Serum Creatinine, μmol/l | 117.6 ± 103.9 | 137.0 ± 99.2 | 127.7 ± 101.6 |
| Length of stay in days, median (IQR) | 5 (3,12), n = 55 | 6 (4,13), n = 53 | 5.5 (3,13), n = 108 |
| Received antibiotics | 21 (30.4) | 25 (31.3) | 47 (30.9) |
| Pneumonia | 16 (23.2) | 26 (31.3) | 42 (28.2) |
| Urinary tract infection | 5 (7.2) | 4 (5.0) | 9 (6.0) |
| Dysphagia screen | |||
| Completed | 52 (75.4) | 67 (83.8) | 119 (79.9) |
| Pass | 31 (59.6) | 30 (44.8) | 61 (51.3) |
*No subjects were taking anticoagulation